GeneDx (WGS) News Today $69.48 +1.22 (+1.79%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Institutional owners may ignore GeneDx Holdings Corp.'s (NASDAQ:WGS) recent US$427m market cap decline as longer-term profits stay in the greenJanuary 20 at 9:22 AM | finance.yahoo.comAssenagon Asset Management S.A. Sells 61,642 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)Assenagon Asset Management S.A. lessened its holdings in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 18.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 267,614 shares of the companyJanuary 18 at 3:40 AM | marketbeat.comGeneDx (NASDAQ:WGS) Sees Unusually-High Trading Volume - What's Next?GeneDx (NASDAQ:WGS) Sees Unusually-High Trading Volume - Here's What HappenedJanuary 16, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Trading Down 7.2% - Here's What HappenedGeneDx (NASDAQ:WGS) Shares Down 7.2% - Should You Sell?January 16, 2025 | marketbeat.comBarclays PLC Raises Stock Position in GeneDx Holdings Corp. (NASDAQ:WGS)Barclays PLC grew its holdings in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 346.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,921 shares of the company's stock after purchasing an adJanuary 16, 2025 | marketbeat.comGeneDx Holdings: A Phenomenal Comeback With More Room To RunJanuary 16, 2025 | seekingalpha.comCraig-Hallum Sticks to Its Buy Rating for GeneDx Holdings (WGS)January 14, 2025 | markets.businessinsider.comGeneDx (NASDAQ:WGS) Sees Large Volume Increase - Here's WhyGeneDx (NASDAQ:WGS) Sees Unusually-High Trading Volume - What's Next?January 14, 2025 | marketbeat.comGeneDx Holdings Estimates Rise In Q4, FY24 Revenues; Stock DownJanuary 13, 2025 | markets.businessinsider.comGeneDx raises Q4 adjusted gross margin view to 68% from 64%January 13, 2025 | markets.businessinsider.comGeneDx anticipates higher-than-expected annual revenuesJanuary 13, 2025 | msn.comGeneDx Announces Preliminary 2024 Financial ResultsJanuary 13, 2025 | businesswire.comGeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $4,858,161.60 in StockJanuary 13, 2025 | americanbankingnews.comInsider Selling: GeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells 35,506 Shares of StockJanuary 11, 2025 | insidertrades.comGeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells $3,331,172.92 in StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CFO Kevin Feeley sold 35,506 shares of GeneDx stock in a transaction dated Tuesday, January 7th. The shares were sold at an average price of $93.82, for a total transaction of $3,331,172.92. Following the transaction, the chief financial officer now owns 2,472 shares of the company's stock, valued at $231,923.04. This represents a 93.49 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.January 10, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CEO Katherine Stueland Sells 51,420 SharesGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CEO Katherine Stueland sold 51,420 shares of the stock in a transaction dated Tuesday, January 7th. The shares were sold at an average price of $94.48, for a total transaction of $4,858,161.60. Following the sale, the chief executive officer now directly owns 1,720 shares in the company, valued at $162,505.60. This trade represents a 96.76 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.January 10, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Stock Price Down 6.3% - Here's What HappenedGeneDx (NASDAQ:WGS) Trading Down 6.3% - Here's WhyJanuary 10, 2025 | marketbeat.comGeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking AnswersJanuary 9, 2025 | businesswire.comGeneDX Slides on Asserting Industry Leadership RoleJanuary 8, 2025 | baystreet.caGeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 PatientsJanuary 8, 2025 | businesswire.comTD Cowen Reaffirms Their Buy Rating on GeneDx Holdings (WGS)January 8, 2025 | markets.businessinsider.comGeneDx price target raised to $118 from $75 at TD CowenJanuary 8, 2025 | markets.businessinsider.comIBD 50's GeneDx Adds To Nearly 2,700% Sprint With FDA Guide On AIJanuary 7, 2025 | yahoo.comTD Cowen Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) StockTD Cowen increased their price objective on GeneDx from $75.00 to $118.00 and gave the company a "buy" rating in a report on Tuesday.January 7, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Hits New 52-Week High - Should You Buy?GeneDx (NASDAQ:WGS) Sets New 52-Week High - Time to Buy?January 7, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells $108,737.20 in StockJanuary 7, 2025 | insidertrades.comKevin Feeley Sells 1,430 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CFO Kevin Feeley sold 1,430 shares of the company's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $76.04, for a total value of $108,737.20. Following the sale, the chief financial officer now owns 26,770 shares in the company, valued at approximately $2,035,590.80. This trade represents a 5.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.January 6, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CEO Katherine Stueland Sells 18,006 SharesGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CEO Katherine Stueland sold 18,006 shares of the business's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $78.18, for a total value of $1,407,709.08. Following the sale, the chief executive officer now directly owns 53,140 shares in the company, valued at $4,154,485.20. The trade was a 25.31 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.January 6, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Stock Price Up 7.3% - Time to Buy?GeneDx (NASDAQ:WGS) Trading 7.3% Higher - Time to Buy?January 6, 2025 | marketbeat.comPrincipal Financial Group Inc. Invests $604,000 in GeneDx Holdings Corp. (NASDAQ:WGS)Principal Financial Group Inc. bought a new stake in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 14,240 shares of the comJanuary 6, 2025 | marketbeat.comMeta Stock, Energy Plays Lead Five Leaders Rebounding BullishlyJanuary 4, 2025 | investors.comGeneDx appoints Bryan Dechairo as COO, effective immediatelyJanuary 2, 2025 | markets.businessinsider.comGeneDx Strengthens Executive Leadership Team with Bryan Dechairo Named Chief Operating OfficerJanuary 2, 2025 | finance.yahoo.comGeneDx Appoints Bryan Dechairo As COOJanuary 2, 2025 | markets.businessinsider.comGeneDx Holdings Appoints Bryan Dechairo as COOJanuary 2, 2025 | tipranks.comFranklin Resources Inc. Acquires New Position in GeneDx Holdings Corp. (NASDAQ:WGS)Franklin Resources Inc. bought a new position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the third quarter, according to its most recent filing with the SEC. The firm bought 7,092 shares of the company's stock, valued at approximately $301,000. Several other large investors also recentlJanuary 2, 2025 | marketbeat.comBarclays PLC Acquires 14,681 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)Barclays PLC increased its stake in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 346.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,921 shares of the company's stock after acquiring an additional 14,681 shares dJanuary 1, 2025 | marketbeat.comGeode Capital Management LLC Boosts Stock Holdings in GeneDx Holdings Corp. (NASDAQ:WGS)Geode Capital Management LLC increased its stake in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 8.7% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 377,631 shares of the company's stock after buying an additional 30,379 shares durinDecember 30, 2024 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Rating of "Moderate Buy" from BrokeragesGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) has been given an average rating of "Moderate Buy" by the six research firms that are currently covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and three have given a buy recommendation to tDecember 30, 2024 | marketbeat.comState Street Corp Purchases 48,735 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)State Street Corp raised its position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 18.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 314,914 shares of the company's stock after purchasing an additional 48,735December 26, 2024 | marketbeat.comGeneDx HoldingsDecember 25, 2024 | forbes.comTidal Investments LLC Buys New Position in GeneDx Holdings Corp. (NASDAQ:WGS)Tidal Investments LLC purchased a new position in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 12,103 shares of the company's stock, valued at approximatelyDecember 23, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New $325,000 Investment in GeneDx Holdings Corp. (NASDAQ:WGS)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 7,647 shares of the companDecember 22, 2024 | marketbeat.comThe top five midcap stocks of 2024December 20, 2024 | fxstreet.comGeneDx (NASDAQ:WGS) Shares Gap Down - Should You Sell?GeneDx (NASDAQ:WGS) Shares Gap Down - What's Next?December 20, 2024 | marketbeat.comKevin Feeley Sells 3,728 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockDecember 19, 2024 | insidertrades.comGeneDx Holdings Corp. (NASDAQ:WGS) CFO Kevin Feeley Sells 3,728 SharesGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CFO Kevin Feeley sold 3,728 shares of GeneDx stock in a transaction on Monday, December 16th. The stock was sold at an average price of $76.75, for a total transaction of $286,124.00. Following the transaction, the chief financial officer now owns 28,200 shares in the company, valued at approximately $2,164,350. This trade represents a 11.68 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.December 18, 2024 | marketbeat.comKatherine Stueland Sells 10,501 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CEO Katherine Stueland sold 10,501 shares of the business's stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $76.75, for a total value of $805,951.75. Following the completion of the sale, the chief executive officer now owns 71,146 shares of the company's stock, valued at approximately $5,460,455.50. This represents a 12.86 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.December 18, 2024 | marketbeat.comGeneDx to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 16, 2024 | businesswire.comGeneDx: Possibly Turning A Profit In 2025 (Rating Downgrade)December 16, 2024 | seekingalpha.com Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Email Address WGS Media Mentions By Week WGS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WGS News Sentiment▼0.410.44▲Average Medical News Sentiment WGS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WGS Articles This Week▼85▲WGS Articles Average Week Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HIMS News Today RDNT News Today OPCH News Today GH News Today SHC News Today VCYT News Today BTSG News Today LFST News Today SGRY News Today CON News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WGS) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaThe Crypto ETF Windfall: 27 Experts Tell All (Free) Don't miss your chance to see exactly what crypto's eli...Crypto 101 Media | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WGS Stock Alerts